We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
801
Atlassian
TEAM
$22B
$10.1K ﹤0.01%
60
STM icon
802
STMicroelectronics
STM
$46B
$10K ﹤0.01%
200
QS icon
803
QuantumScape Corp
QS
$3B
$9.84K ﹤0.01%
1,231
PFG icon
804
Principal Financial Group
PFG
$23.6B
$9.71K ﹤0.01%
+128
New +$9.23K
FFIV icon
805
F5
FFIV
$22.1B
$9.65K ﹤0.01%
66
X
806
DELISTED
US Steel
X
$9.63K ﹤0.01%
385
+21
+6% +$489
UMH
807
UMH Properties
UMH
$1.32B
$9.59K ﹤0.01%
600
SKYY icon
808
First Trust Cloud Computing ETF
SKYY
$2.74B
$9.57K ﹤0.01%
126
NVAX icon
809
Novavax
NVAX
$1.23B
$9.46K ﹤0.01%
1,273
+65
+5% +$511
HCA icon
810
HCA Healthcare
HCA
$84.8B
$9.41K ﹤0.01%
+31
New +$8.62K
KLAC icon
811
KLA
KLAC
$275B
$9.22K ﹤0.01%
190
PGX icon
812
Invesco Preferred ETF
PGX
$3.84B
$9.21K ﹤0.01%
810
NNN icon
813
NNN REIT
NNN
$9.39B
$9.2K ﹤0.01%
215
EWJ icon
814
iShares MSCI Japan ETF
EWJ
$21.7B
$9.04K ﹤0.01%
146
BRKL
815
DELISTED
Brookline Bancorp
BRKL
$8.74K ﹤0.01%
1,000
+500
+100% +$4.56K
OKE icon
816
Oneok
OKE
$58.7B
$8.64K ﹤0.01%
140
FOX icon
817
Fox Class B
FOX
$20.7B
$8.42K ﹤0.01%
264
SONO icon
818
Sonos
SONO
$1.75B
$8.16K ﹤0.01%
500
-1,800
-78% -$31.9K
NLY icon
819
Annaly Capital Management
NLY
$16.9B
$8K ﹤0.01%
400
ARKW icon
820
ARK Web x.0 ETF
ARKW
$1.64B
$7.91K ﹤0.01%
135
VRTX icon
821
Vertex Pharmaceuticals
VRTX
$121B
$7.74K ﹤0.01%
22
HOOD icon
822
Robinhood
HOOD
$85.2B
$7.64K ﹤0.01%
766
ROKU icon
823
Roku
ROKU
$21.1B
$7.55K ﹤0.01%
118
VREX icon
824
Varex Imaging
VREX
$460M
$7.54K ﹤0.01%
320
GEM icon
825
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.63B
$7.47K ﹤0.01%
+250
New +$7.45K

Similar funds

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.